ACE2 and COVID-19: To determine whether ACE2+ exosomes are generated and are present in the respiratory tract, we analyzed bronchoalveolar lavage fluid (BALF) samples from 80 critically ill COVID-19 patients [22] using biochemical fractionation to enrich for exosomes followed by flow cytometry [9].